Bloomberg News

Walgreen Gains After Renewing Pact With Express Scripts

July 19, 2012

Walgreen Reaches Pharmacy Network Pact With Express Scripts

Walgreen Co. jumped as much as 17 percent to $36.35 in early trading in New York. Photographer: Daniel Acker/Bloomberg

Walgreen Co. (WAG:US), the largest U.S. drugstore chain, surged the most since 2008 after renewing a contract to provide Express Scripts Inc. customers with prescriptions, ending a dispute that contributed to an 11 percent decline in the retailer’s quarterly profit.

Walgreen, based in Deerfield, Illinois, surged (WAG:US) 12 percent to $34.62 at 4:15 p.m. in New York for the biggest gain since Oct. 28, 2008. Express Scripts rose (ESRX:US) 1.9 percent to $58.76.

Walgreen will become part of the network of pharmacies available to Express Scripts clients as of Sept. 15, the companies said today in a statement. Terms weren’t disclosed.

The agreement ends a standoff that centered on reimbursement rates and caused Walgreen to lose customers to CVS Caremark Corp. (CVS:US), Wal-Mart Stores Inc. (WMT:US) and other drugstore rivals. The contract with Express Scripts, which ended on Dec. 31, had generated $5.3 billion in annual sales (WAG:US) for Walgreen.

The pact “removes significant overhang for Walgreen,” Ross Muken, an analyst at International Strategy & Investment Group LLC in New York, wrote today in a note. He rates the shares as underweight, equivalent to a sell recommendation.

Rival drugstore chains CVS fel (CVS:US)l 6.5 percent to $45.43 and Rite Aid Corp. (RAD:US)declined (RAD:US) 6.3 percent to $1.20. Walgreen shares have slumped 20 percent from June 21, 2011, when it announced it didn’t plan to renew its contract with St. Louis-based Express Scripts.

Impact on CVS

CVS said today in a statement that it expects to boost profit by about 5 cents a share in the third and fourth quarters from the impasse between Walgreen and Express Scripts. It anticipates retaining at least half of the business taken from Walgreen in the fourth quarter.

CVS, based in Woonsocket, Rhode Island, raised its full- year earnings forecast in May and projected a benefit of as much as 4 cents a share in the second quarter from the dispute.

The revenue generated from Express Scripts represented about 7.3 percent of Walgreen’s $72.2 billion in sales (WAG:US) in fiscal 2011.

Express Scripts manages pharmacy benefit programs for private employers, unions and government health plans. The dispute revolved around reimbursement rates for 88 million prescriptions, or 10 percent of Walgreen’s pharmacy business. Wal-Mart, CVS and Rite Aid had stepped up marketing to grab Walgreen’s prescription customers amid the impasse.

Earlier this month, Walgreen agreed to buy the owner of the USA Drug chain for about $438 million to add stores in the southern U.S. In June, Walgreen entered into a pact to purchase a 45 percent stake in Alliance Boots GmbH for $6.7 billion to create a global chain of pharmacies. Alliance is the U.K.’s largest drugstore-chain company.

Walgreen last week named retired McDonald’s Corp. (MCD:US) Chief Executive Officer James Skinner as nonexecutive chairman, replacing Al McNally as part of the board’s rotation of directors. Skinner, 67, has served as a Walgreen director since 2005.

To contact the reporter on this story: Chris Burritt in Greensboro at cburritt@bloomberg.net

To contact the editors responsible for this story: James Callan at jcallan2@bloomberg.net; Robin Ajello at rajello@bloomberg.net


Ebola Rising
LIMITED-TIME OFFER SUBSCRIBE NOW

Companies Mentioned

  • WAG
    (Walgreen Co)
    • $59.04 USD
    • -0.23
    • -0.39%
  • ESRX
    (Express Scripts Holding Co)
    • $70.07 USD
    • -0.56
    • -0.8%
Market data is delayed at least 15 minutes.
 
blog comments powered by Disqus